ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar jwpao (76.38) Submitted: 6/24/2012 8:16:49 AM : Outperform Start Price: $1.49 ACAD Score: +799.75

no debt

Featured Broker Partners


Advertisement